Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

We initiated a prospective multicenter phase II trial using rituximab and temozolomide in immunocompetent patients with progressive or recurrent primary central nervous system lymphoma (PCNSL) based on activity observed in retrospective studies. Treatment consisted of an induction phase with rituxim...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Leuk Lymphoma
Hlavní autoři: Nayak, Lakshmi, Abrey, Lauren E., Drappatz, Jan, Gilbert, Mark R., Reardon, David A., Wen, Patrick Y., Prados, Michael, Deangelis, Lisa M., Omuro, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802006/
https://ncbi.nlm.nih.gov/pubmed/22656234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.698736
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky